Ameriflex Group, Inc. Rhythm Pharmaceuticals, Inc. Transaction History
Ameriflex Group, Inc.
- $218 Billion
- Q4 2024
A detailed history of Ameriflex Group, Inc. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameriflex Group, Inc. holds 360 shares of RYTM stock, worth $20,185. This represents 0.01% of its overall portfolio holdings.
Number of Shares
360Holding current value
$20,185% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RYTM
# of Institutions
214Shares Held
64.4MCall Options Held
445KPut Options Held
26.6K-
Black Rock Inc. New York, NY6.74MShares$378 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA6.57MShares$368 Million0.29% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$341 Million5.51% of portfolio
-
Baker Bros. Advisors LP New York, NY6.08MShares$341 Million3.77% of portfolio
-
Perceptive Advisors LLC New York, NY3.68MShares$206 Million6.86% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.12B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...